Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Eur J Epidemiol ; 2(2): 90-4, 1986 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-3464454

RESUMEN

Transformation of pneumococcus was used to detect homology among tetracycline resistance determinants of clinical isolates of Streptococcus pneumoniae. A strain of pneumococcus containing a mutated tet determinant (tet-3), of class M, integrated into the chromosome was used as a recipient in transformation experiments, where donor DNA was from the tetracycline resistant isolates. 34/34 strains appeared to have tet determinants homologous to tet-3 (i.e. tet M). Still using transformation it was possible to determine that the tet-3 transforming activity of DNA from Tn916 and S. pneumoniae BM6001 was contained in a 5 kb HincII fragment. For this purpose a transformation technique where donor DNA was directly taken from low melting point agarose gels was standardized and used.


Asunto(s)
Marcadores Genéticos , Streptococcus pneumoniae/genética , Tetraciclina/farmacología , Transformación Bacteriana , ADN Bacteriano/genética , Farmacorresistencia Microbiana , Streptococcus pneumoniae/efectos de los fármacos
2.
Clin Infect Dis ; 32(5): E90-1, 2001 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-11229864

RESUMEN

We describe a patient who became cushingoid as a result of receiving steroid therapy for thrombocytopenia purpura and who then developed spinal epidural lipomatosis 4 months after he started receiving ritonavir as part of his therapy for human immunodeficiency virus infection. We believe that ritonavir may have contributed to the development of epidural lipomatosis and that clinicians should be aware of this possible association.


Asunto(s)
Infecciones por VIH/tratamiento farmacológico , Inhibidores de la Proteasa del VIH/efectos adversos , Lipomatosis/inducido químicamente , Ritonavir/efectos adversos , Enfermedades de la Columna Vertebral/inducido químicamente , Adulto , Fármacos Anti-VIH/efectos adversos , Antiinflamatorios/uso terapéutico , Dexametasona/uso terapéutico , Quimioterapia Combinada , Espacio Epidural , Infecciones por VIH/complicaciones , Humanos , Lipomatosis/patología , Imagen por Resonancia Magnética , Masculino , Púrpura Trombocitopénica/complicaciones , Púrpura Trombocitopénica/tratamiento farmacológico , Enfermedades de la Columna Vertebral/patología
3.
J Nutr ; 114(12): 2283-91, 1984 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-6502272

RESUMEN

The effect of depot parenteral injections of zinc (110 mg Zn/kg body weight) on copper metabolism in young, male rats was investigated. Individually caged rats, fed known amounts of stock diet and deionized-distilled water, were injected s.c. weekly for the first 4 weeks and biweekly for the next 17 weeks with zinc in sesame oil or the oil vehicle only. No significant differences in body weight, hemoglobin, hematocrit and fecal copper excretions were observed between treatments. However, 2 weeks after the initial injections, urinary copper excretion was elevated in the zinc-injected animals and remained elevated throughout the rest of the study. Plasma copper concentrations were significantly higher in the zinc-injected animals from week 2 to 8 of the study, and plasma zinc concentrations of these injected animals were elevated (P less than 0.05) from week 2 and throughout the remainder of the study. Zinc concentrations were significantly higher in the liver, heart, kidney and spleen (P less than 0.05) and copper concentrations were lower in the liver (P less than 0.07), kidney and spleen (P less than 0.05) of zinc-injected animals compared to the vehicle-treated control animals. The data indicate that when zinc is administered by a non-gastrointestinal route, the fecal excretion of copper, the major route of copper excretion, is not altered. Thus, a negative copper balance is not initiated by high levels of zinc administered by the depot technique, in contrast to the negative copper balance stimulated by the gastrointestinal administration of zinc.


Asunto(s)
Cobre/metabolismo , Zinc/farmacología , Absorción , Animales , Peso Corporal , Cobre/sangre , Preparaciones de Acción Retardada , Interacciones Farmacológicas , Heces/análisis , Hematócrito , Inyecciones Subcutáneas , Masculino , Ratas , Ratas Endogámicas , Espectrofotometría Atómica , Distribución Tisular , Zinc/sangre
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda